Hello economist listeners, my name is Mark Leon Goldberg, host of Global Dispatches,

which the Guardian has called a podcast to make you smarter. I've hosted Presidents and Prime

Ministers, Frontline Adworkers and Journalists, all to give listeners a deeper understanding of

world affairs. Global dispatches is for people who seek world news that does not often make

the headlines, but should. Find global dispatches, world news that matters, wherever you listen to your podcasts.

Hello and welcome to the Intelligence from the Economist. I'm your host Jason Palmer.

Every weekday we provide a fresh perspective on the events shaping your world.

In the second installment of our series on the French presidential election, we look left.

The country's storied socialist party is in the doldrums, and the field of left-leaning candidates

is big, too big for its own good. And as the Winter Olympics come to a close, our data team puts

numbers to a problem you might have guessed exists, judges favoring competitors from their own

countries. We even get a sense for how many metals may have been wrongly awarded.

First up, though.

This week, a potential new chapter opened in the coronavirus vaccine tale.

The lightning fast development of vaccines has played out as the science success story of the

century, but this new future is not evenly distributed. Many in poor countries haven't had a

single jab yet. Only about 11% of Africa's population is fully vaccinated. Now, by on-tech,

a German company that helped develop the first widely approved vaccine wants to put production

facilities, lots of them, where they're needed. Yesterday, by on-tech unveiled a new way of making

vaccines, and they want to do it inside shipping containers. How hard is our technology

corresponded? For the last eight months, they have been working on porting their manufacturing

process out of their existing factories. And the idea is that once you've got the production

...